Answers are grounded in this paper and cite their sources.
Ageing is a major biological context for late-onset Alzheimer disease (AD), but its relationship with AD neuroinflammation remains incompletely understood. This review compares immune and glial changes in physiological brain ageing and AD using single-cell, single-nucleus, and spatial transcriptomic studies of human tissue and experimental models. Interferon response, phagocytic, and lipid-handling gene programs recur in both settings, while their cellular sources and spatial distributions vary with brain region, genotype, and pathology. Myelin-associated responses in aged white matter and plaque-associated glial environments in AD show how similar programs occur around different substrates. Tau-associated and vascular changes provide further tissue contexts for comparison. Most human studies are cross-sectional, so molecular similarity or spatial co-occurrence cannot establish functional equivalence or a causal progression from ageing to AD. Combining expression profiles with genetic perturbation, cellular function, and tissue localization can guide mechanistic testing and biomarker development.
No takes yet. Share an insight, caveat, or question.
Guan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: